Pursuing transparency

  • EFPIA Japan believes that patients and stakeholders expect companies to be transparent in the medical and pharmaceutical area. Disclosure of concerned processes including why and how specific collaborations are taking place in specific areas of development and distribution of products allow patients and stakeholders to understand the whole picture and the objectives being served.
  • Below is the JPMA Transparency Guideline by which all JPMA members are required to follow.